The currently available drug eluting stents have demonstrated their ability to improve the outcomes of percutaneous coronary intervention, to reduce the rate of restenosis and stent thrombosis while providing a permanent scaffolding. However, there is no consensus on how long this scaffolding is required. Moreover, some safety concerns have emerged because of the permanent presence of a foreign body within the vessel which may cause inflammationn neoatherosclerosis and impaired vasomotor function. Bioabsorbable scaffolds have the p[otentio0al to ocercome these mitiation by providing temporary scaffolding. Vascular restoration therapy with fully bioabsorbable devices can be consider as a new era of interventional cardiology.
